ArticleFrontiers in psychiatry2026
Time to notice neurodiversity in eating disorder services: a three-year real-world analysis of autism, ADHD, and AuDHD.
Article in Frontiers in psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Autism and ADHD frequently co-occur and each of them are overrepresented in clinical eating disorder (ED) services, where they are associated with longer treatment, poorer treatment experiences, and worse clinical outcomes. Separately, Autistic and ADHD patients with EDs present with greater ED psychopathology, anxiety, and depression. Autistic patients also present with poorer quality of life, increased suicide attempts, and greater functional difficulties. However, no study has directly compared patients with EDs who are both Autistic and ADHD (AuDHD) with Autistic-only, ADHD-only, or neurotypical patients. Method: This cross-sectional, observational study compared ED psychopathology (EDE-Q), psychological distress (CORE10), and work and social functioning (WSAS) across adult ED patients reporting suspected or known Autism, ADHD, both, or neither. No formal hypotheses were pre-specified. Data were three-years of routinely collected intake information from a specialist adult ED service. Patients were classified as Autistic or ADHD if they reported a diagnosis/suspicion at intake, or, for ADHD, if they reported ADHD medication. Results: Of 1,252 patients, 32 (2.6%) were classified as AuDHD, 45 (3.5%) as Autistic-only, and 81 (6.5%) as ADHD-only. Group differences were small but consistent. EDE-Q scores were highest in the ADHD-only group and lowest in the Neither group ((M = 4.24 Discussion: Autistic and/or ADHD patients with EDs showed greater psychological distress, and poorer functioning, particularly when both were present. ADHD was particularly linked to increased ED psychopathology. Screening for neurodivergence in ED services may support person-centred care and improve outcomes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.